Atorvastatin Calcium

Product NDC: 62175-892
11-digit product format: 621750892
Labeler code: 62175
Product ID: 62175-892_e20ad87d-3bf3-4d7d-a014-70dc5ef98e7f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Atorvastatin Calcium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Lannett Company, Inc.
Application: ANDA091624
Marketing category: ANDA
Marketing start: 2013-04-05
Marketing end: 0000-00-00
Substance: ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 40 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	62175-892		D	Discontinued by firm	2026-08-07
excluded package	package	62175-892	62175-892-41	D	Discontinued by firm	2026-08-07
excluded package	package	62175-892	62175-892-44	D	Discontinued by firm	2026-08-07
excluded package	package	62175-892	62175-892-46	D	Discontinued by firm	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62175-892-46	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62175-892-44	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62175-892-41	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62175-892-46	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62175-892-44	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62175-892-41	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62175-892-46	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62175-892-44	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62175-892-41	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62175-892-46	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62175-892-44	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62175-892-41	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62175-892-46	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62175-892-44	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62175-892-41	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62175-892-46	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62175-892-44	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62175-892-41	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62175-892-46	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62175-892-44	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62175-892-41	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62175-892-46	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62175-892-44	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62175-892-41	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62175-892-46	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62175-892-44	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62175-892-41	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A091624-001	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05
A091624-002	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05
A091624-003	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05
A091624-004	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A091624-001	AB
A091624-002	AB
A091624-003	AB
A091624-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091624-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2013-04-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091624-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2013-04-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091624-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2013-04-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091624-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2013-04-05	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A091624-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091624-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091624-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091624-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091624-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091624-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091624-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091624-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091624-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091624-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091624-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091624-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091624-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091624-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091624-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091624-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091624-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091624-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091624-004	AB	1	`d06236e962d9…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fa898d56-9495-d6f0-309b-68a5d8e3914a	Product name	4	20260305
d25cba4b-d79e-4890-8837-1382f7d09489	Product name	1	20231002
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
91774e91-b249-45e3-8ff8-4b5db2927a69	Product name	1	20230718
03fb3cda-d60a-4873-94e9-6fa77cfb1a1c	Product name	1	20220302
34152997-af0b-acf4-dcaf-37211afe8ca4	Product name	9	20210312
46fdf265-6d5a-1bfb-93db-d82a4ea8aa81	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62175-892-41	EA - Each	62175-892	06940182-e5c4-47b8-9a17-36233986854b	1	2013-05-02
62175-892-46	EA - Each	62175-892	ed40ac0f-f00d-42cf-b6bc-b30baed0c6a1	1	2013-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ATORVASTATIN CALCIUM TRIHYDRATE	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	INACTIVE INGREDIENT	905HNO1SIH	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ATORVASTATIN CALCIUM TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.]	8
ATORVASTATIN CALCIUM	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [NORTHWIND PHARMACEUTICALS, LLC]	1
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [NORTHWIND PHARMACEUTICALS, LLC]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	062f997d-1b21-4657-9dfa-99cb318d4479	100
617311	atorvastatin 40 MG Oral Tablet	SCD	062f997d-1b21-4657-9dfa-99cb318d4479	100
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	062f997d-1b21-4657-9dfa-99cb318d4479	100
617312	atorvastatin calcium 10 MG Oral Tablet	PSN	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617310	atorvastatin calcium 20 MG Oral Tablet	PSN	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617312	atorvastatin 10 MG Oral Tablet	SCD	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617310	atorvastatin 20 MG Oral Tablet	SCD	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617311	atorvastatin 40 MG Oral Tablet	SCD	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617312	atorvastatin (as atorvastatin calcium) 10 MG Oral Tablet	SY	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617310	atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet	SY	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	e1d39d2f-7c65-4b68-acfa-0d345714ce6e	8
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	888a969b-95e0-296c-e053-2995a90afa24	7
617311	atorvastatin 40 MG Oral Tablet	SCD	888a969b-95e0-296c-e053-2995a90afa24	7
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	888a969b-95e0-296c-e053-2995a90afa24	7
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	ba63a6f7-e09c-7cae-e053-2995a90a829e	1
617311	atorvastatin 40 MG Oral Tablet	SCD	ba63a6f7-e09c-7cae-e053-2995a90a829e	1
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	ba63a6f7-e09c-7cae-e053-2995a90a829e	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
62175-892-41	62175089241	500 TABLET, FILM COATED in 1 BOTTLE (62175-892-41)	2013-04-05	0000-00-00	No	No	Current
62175-892-44	62175089244	2500 TABLET, FILM COATED in 1 BOTTLE (62175-892-44)	2013-04-05	0000-00-00	No	No	Current
62175-892-46	62175089246	90 TABLET, FILM COATED in 1 BOTTLE (62175-892-46)	2013-04-05	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Atorvastatin Calcium	RPK Pharmaceuticals, Inc.	2023-06-07	HUMAN PRESCRIPTION DRUG LABEL	8
Atorvastatin Calcium	St. Mary's Medical Park Pharmacy	2022-05-12	HUMAN PRESCRIPTION DRUG LABEL	8
Atorvastatin Calcium	Bryant Ranch Prepack	2022-02-23	HUMAN PRESCRIPTION DRUG LABEL	100
Atorvastatin Calcium	NuCare Pharmaceuticals,Inc.	2021-02-16	HUMAN PRESCRIPTION DRUG LABEL	3
Atorvastatin Calcium	NuCare Pharmaceuticals,Inc.	2021-02-12	HUMAN PRESCRIPTION DRUG LABEL	4
Atorvastatin Calcium	NuCare Pharmaceuticals,Inc.	2021-02-02	HUMAN PRESCRIPTION DRUG LABEL	1
ATORVASTATIN 40MG	RedPharm Drug, Inc.	2021-01-13	HUMAN PRESCRIPTION DRUG LABEL	7
Atorvastatin Calcium	Lannett Company, Inc.	2020-12-08	HUMAN PRESCRIPTION DRUG LABEL	23
Atorvastatin Calcium	NuCare Pharmaceuticals,Inc.	2020-09-17	HUMAN PRESCRIPTION DRUG LABEL	2
Atorvastatin Calcium	Preferred Pharmaceuticals Inc.	2020-03-13	HUMAN PRESCRIPTION DRUG LABEL	5
Atorvastatin Calcium	REMEDYREPACK INC.	2019-08-19	HUMAN PRESCRIPTION DRUG LABEL	3
Atorvastatin Calcium	NuCare Pharmaceuticals, Inc.	2017-03-13	HUMAN PRESCRIPTION DRUG LABEL	1
ATORVASTATIN CALCIUM	Northwind Pharmaceuticals, LLC	2014-10-21	HUMAN PRESCRIPTION DRUG LABEL	1